Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on JNJ 141. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105753770A reveals a safer Negishi coupling route for kinase inhibitors, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.